BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Seraphim A, Westwood M, Bhuva AN, Crake T, Moon JC, Menezes LJ, Lloyd G, Ghosh AK, Slater S, Oakervee H, Manisty CH. Advanced Imaging Modalities to Monitor for Cardiotoxicity. Curr Treat Options Oncol 2019;20:73. [PMID: 31396720 DOI: 10.1007/s11864-019-0672-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Afrin H, Huda MN, Islam T, Oropeza BP, Alvidrez E, Abir MI, Boland T, Turbay D, Nurunnabi M. Detection of Anticancer Drug-Induced Cardiotoxicity Using VCAM1-Targeted Nanoprobes. ACS Appl Mater Interfaces 2022. [PMID: 35939041 DOI: 10.1021/acsami.2c13019] [Reference Citation Analysis]
2 Gálvez LC, Redondo EA, Lorenzo CC, Fernández TL. Advanced Echocardiographic Techniques in Cardio-Oncology: the Role for Early Detection of Cardiotoxicity. Curr Cardiol Rep 2022. [PMID: 35881319 DOI: 10.1007/s11886-022-01728-y] [Reference Citation Analysis]
3 Gambril JA, Chum A, Goyal A, Ruz P, Mikrut K, Simonetti O, Dholiya H, Patel B, Addison D. Cardiovascular Imaging in Cardio-Oncology: The Role of Echocardiography and Cardiac MRI in Modern Cardio-Oncology. Heart Fail Clin 2022;18:455-78. [PMID: 35718419 DOI: 10.1016/j.hfc.2022.02.007] [Reference Citation Analysis]
4 Afrin H, Salazar CJ, Kazi M, Ahamad SR, Alharbi M, Nurunnabi M. Methods of screening, monitoring and management of cardiac toxicity induced by chemotherapeutics. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.01.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Seiffert AP, Gómez-Grande A, Castro-Leal G, Rodríguez A, Palomino-Fernández D, Gómez EJ, Sánchez-González P, Bueno H. An image processing tool for the detection of anthracycline-induced cardiotoxicity by evaluating the myocardial metabolic activity in [18F]FDG PET/CT. Int J Comput Assist Radiol Surg 2021. [PMID: 34698987 DOI: 10.1007/s11548-021-02508-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Saunderson CED, Plein S, Manisty CH. Role of cardiovascular magnetic resonance imaging in cardio-oncology. Eur Heart J Cardiovasc Imaging 2021;22:383-96. [PMID: 33404058 DOI: 10.1093/ehjci/jeaa345] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
7 de Wall C, Bauersachs J, Berliner D. Cardiooncology-dealing with modern drug treatment, long-term complications, and cancer survivorship. Clin Exp Metastasis 2021;38:361-71. [PMID: 34117981 DOI: 10.1007/s10585-021-10106-x] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Dobson R, Ghosh AK, Ky B, Marwick T, Stout M, Harkness A, Steeds R, Robinson S, Oxborough D, Adlam D, Stanway S, Rana B, Ingram T, Ring L, Rosen S, Plummer C, Manisty C, Harbinson M, Sharma V, Pearce K, Lyon AR, Augustine DX; British Society of Echocardiography., British Society of Cardio-Oncology. British Society for Echocardiography and British Cardio-Oncology Society guideline for transthoracic echocardiographic assessment of adult cancer patients receiving anthracyclines and/or trastuzumab. Echo Res Pract 2021;8:G1-G18. [PMID: 34106116 DOI: 10.1530/ERP-21-0001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Dobson R, Ghosh AK, Ky B, Marwick T, Stout M, Harkness A, Steeds R, Robinson S, Oxborough D, Adlam D, Stanway S, Rana B, Ingram T, Ring L, Rosen S, Plummer C, Manisty C, Harbinson M, Sharma V, Pearce K, Lyon AR, Augustine DX; British Society of Echocardiography (BSE) and theBritish Society of Cardio-Oncology (BCOS). BSE and BCOS Guideline for Transthoracic Echocardiographic Assessment of Adult Cancer Patients Receiving Anthracyclines and/or Trastuzumab. JACC CardioOncol 2021;3:1-16. [PMID: 34396303 DOI: 10.1016/j.jaccao.2021.01.011] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
10 Chen DH, Tyebally S, Mallouppas M, Ghosh AK. CAR T Cell and BiTE Therapy—New Therapies, New Risks? Curr Cardiovasc Risk Rep 2021;15. [DOI: 10.1007/s12170-020-00661-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Lin Y, Wang J, Xu M, Qiu C, Xu P, Shang L, He B, Wang F, Yue Y, Guo Y, Li F, Dong W, Xie X, Wang Y, Gu W. Summed rest score in gated myocardial perfusion imaging is a good predicator for treatment-related cardiotoxicity after anthracycline chemotherapy in patients with diffuse large B-cell lymphoma. Oncol Lett 2020;20:330. [PMID: 33133255 DOI: 10.3892/ol.2020.12194] [Reference Citation Analysis]
12 Loar RW, Pignatelli RH, Tunuguntla HP, Rainusso NC, Gramatges MM, Plana JC, Noel CV. Improving reproducibility of left ventricular ejection fraction in pediatric oncology patients: less is more. Int J Cardiovasc Imaging 2020;36:1887-95. [PMID: 32488453 DOI: 10.1007/s10554-020-01901-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Lenihan D, Carver J, Porter C, Liu JE, Dent S, Thavendiranathan P, Mitchell JD, Nohria A, Fradley MG, Pusic I, Stockerl-Goldstein K, Blaes A, Lyon AR, Ganatra S, López-Fernández T, O'Quinn R, Minotti G, Szmit S, Cardinale D, Alvarez-Cardona J, Curigliano G, Neilan TG, Herrmann J. Cardio-oncology care in the era of the coronavirus disease 2019 (COVID-19) pandemic: An International Cardio-Oncology Society (ICOS) statement. CA Cancer J Clin 2020;70:480-504. [PMID: 32910493 DOI: 10.3322/caac.21635] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
14 Jiang L, Ping L, Yan H, Yang X, He Q, Xu Z, Luo P. Cardiovascular toxicity induced by anti-VEGF/VEGFR agents: a special focus on definitions, diagnoses, mechanisms and management. Expert Opin Drug Metab Toxicol 2020;16:823-35. [PMID: 32597258 DOI: 10.1080/17425255.2020.1787986] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Cau R, Bassareo P, Cherchi V, Palmisano V, Suri JS, Porcu M, Balestrieri A, Pontone G, Saba L. Early diagnosis of chemotherapy-induced cardiotoxicity by cardiac MRI. Eur J Radiol 2020;130:109158. [PMID: 32652404 DOI: 10.1016/j.ejrad.2020.109158] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
16 Berliner D, Beutel G, Bauersachs J. Echocardiography and biomarkers for the diagnosis of cardiotoxicity. Herz 2020;45:637-44. [DOI: 10.1007/s00059-020-04957-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
17 Feroze RA, Leya J, Herron T, Hayek SS. Clinical and Research Tools for the Study of Cardiovascular Effects of Cancer Therapy. J Cardiovasc Transl Res 2020;13:417-30. [PMID: 32472498 DOI: 10.1007/s12265-020-10030-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Amano Y, Omori Y, Ando C, Yanagisawa F, Suzuki Y, Tang X, Kobayashi H, Takagi R, Matsumoto N. Clinical Importance of Myocardial T2 Mapping and Texture Analysis. Magn Reson Med Sci 2021;20:139-51. [PMID: 32389929 DOI: 10.2463/mrms.rev.2020-0007] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
19 Ghosh AK, Chen DH, Guha A, Mackenzie S, Walker JM, Roddie C. CAR T Cell Therapy-Related Cardiovascular Outcomes and Management: Systemic Disease or Direct Cardiotoxicity? JACC CardioOncol 2020;2:97-109. [PMID: 34396213 DOI: 10.1016/j.jaccao.2020.02.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 6.5] [Reference Citation Analysis]
20 Biersmith MA, Tong MS, Guha A, Simonetti OP, Addison D. Multimodality Cardiac Imaging in the Era of Emerging Cancer Therapies. J Am Heart Assoc 2020;9:e013755. [PMID: 31960741 DOI: 10.1161/JAHA.119.013755] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 6.5] [Reference Citation Analysis]